(19)
(11)EP 3 090 261 B8

(12)CORRECTED EUROPEAN PATENT SPECIFICATION
Note: Bibliography reflects the latest situation

(15)Correction information:
Corrected version no 1 (W1 B1)

(48)Corrigendum issued on:
26.06.2019 Bulletin 2019/26

(45)Mention of the grant of the patent:
20.03.2019 Bulletin 2019/12

(21)Application number: 15700814.5

(22)Date of filing:  02.01.2015
(51)International Patent Classification (IPC): 
G01N 33/50(2006.01)
G01N 33/68(2006.01)
G01N 21/00(2006.01)
(86)International application number:
PCT/US2015/010066
(87)International publication number:
WO 2015/103495 (09.07.2015 Gazette  2015/27)

(54)

CONVERGENCE OF AGGREGATION RATE WITH VALIDATED PERIPHERAL DIAGNOSTICS FOR ALZHEIMER'S DISEASE

KONVERGENZ VON AGGREGATIONSGESCHWINDIGKEIT MIT VALIDIERTEN PERIPHEREN DIAGNOSTISCHEN VERFAHREN FÜR ALZHEIMER

CONVERGENCE DU TAUX D'AGRÉGATION ASSOCIÉS À DES DIAGNOSTICS PÉRIPHÉRIQUES VALIDÉS DE LA MALADIE D'ALZHEIMER


(84)Designated Contracting States:
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR

(30)Priority: 03.01.2014 US 201461923373 P

(43)Date of publication of application:
09.11.2016 Bulletin 2016/45

(73)Proprietor: The West Virginia University Board of Governors on behalf of West Virginia University
Morgantown, WV 26505-6204 (US)

(72)Inventors:
  • CHIRILA, Florin V.
    Morgantown, WV 26505 (US)
  • KHAN, Tapan K.
    Morgantown, WV 26505 (US)
  • ALKON, Daniel
    Chevy Chase, MD 20815 (US)

(74)Representative: Finnegan Europe LLP 
1 London Bridge
London SE1 9BG
London SE1 9BG (GB)


(56)References cited: : 
WO-A1-2011/041761
US-A1- 2007 082 366
WO-A1-2012/155051
  
  • CHIRILA FLORIN V ET AL: "Spatiotemporal Complexity of Fibroblast Networks Screens for Alzheimer's Disease", JOURNAL OF ALZHEIMER'S DISEASE, IOS PRESS, NL, vol. 33, no. 1, 1 January 2013 (2013-01-01), pages 165-176, XP009182993, ISSN: 1387-2877
  
Note: Within nine months from the publication of the mention of the grant of the European patent, any person may give notice to the European Patent Office of opposition to the European patent granted. Notice of opposition shall be filed in a written reasoned statement. It shall not be deemed to have been filed until the opposition fee has been paid. (Art. 99(1) European Patent Convention).